Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancy

Transfusion

Volumn 50, Issue 12, 2010, Pages 2660-2669

  Myers, Jay ^a   Huang, Yuanshuai ^a   Wei, Lebing ^a   Yan, Quanjian ^a   Huang, Alex ^a   Zhou, Lan ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSE;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CALVARIA; CELL CYCLE; CELL HOMING; CELL RENEWAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; IN VIVO STUDY; MICROSCOPY; MOUSE; NONHUMAN; WILD TYPE;

ANIMALS; BONE MARROW; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COMPUTER SIMULATION; FEMALE; FUCOSE; HEMATOPOIETIC STEM CELLS; HUMANS; HYDRO-LYASES; MICE; MICE, KNOCKOUT; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, NOTCH; STEM CELL NICHE;

EID: 78649987445     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02745.x     Document Type: Article

References (43)

1. Wilson A, Trumpp A,. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006; 6: 93-106.
2. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L,. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-41.
3. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT,. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-6.
4. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A,. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18: 2747-63.
5. Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD,. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 4: 37-48.
6. Walkley CR, Fero ML, Chien WM, Purton LE, McArthur GA,. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2005; 7: 172-8.
7. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT,. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287: 1804-8.
8. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T,. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-61.
9. Purton LE, Bernstein ID, Collins SJ,. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000; 95: 470-7.
10. Sugiyama T, Kohara H, Noda M, Nagasawa T,. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25: 977-88.
11. Kojika S, Griffin JD,. Notch receptors and hematopoiesis. Exp Hematol 2001; 29: 1041-52.
12. Haltiwanger RS,. Regulation of signal transduction pathways in development by glycosylation. Curr Opin Struct Biol 2002; 12: 593-8.
13. Zhou L, Li LW, Yan Q, Petryniak B, Man Y, Su C, Shim J, Chervin S, Lowe JB,. Notch-dependent control of myelopoiesis is regulated by fucosylation. Blood 2008; 112: 308-19.
14. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS, Bernstein ID,. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6: 1278-81.
15. Carlesso N, Aster JC, Sklar J, Scadden DT,. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999; 93: 838-48.
16. Ohishi K, Varnum-Finney B, Bernstein ID,. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest 2002; 110: 1165-74.
17. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT,. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99: 2369-78.
18. Radtke F, Wilson A, Stark G, Bauer M, Van Meerwijk J, MacDonald HR, Aguet M,. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 547-58.
19. Mancini SJ, Mantei N, Dumortier A, Suter U, MacDonald HR, Radtke F,. Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 2005; 105: 2340-2.
20. Maillard I, Koch U, Dumortier A, Shestova O, Xu L, Sai H, Pross SE, Aster JC, Bhandoola A, Radtke F, Pear WS,. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2008; 2: 356-66.
21. Smith PL, Myers JT, Rogers CE, Zhou L, Petryniak B, Becker DJ, Homeister JW, Lowe JB,. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol 2002; 158: 801-15.
22. Yan Q, Yao D, Wei LL, Huang Y, Myers J, Zhang L, Xin W, Shim J, Man Y, Petryniak B, Gerson S, Lowe JB, Zhou L,. O-fucose modulates notch-controlled blood lineage commitment. Am J Pathol 2010; 176: 2921-34.
23. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, Reya T,. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314-22. (Pubitemid 41724769)
24. Heinzel K, Benz C, Martins VC, Haidl ID, Bleul CC,. Bone marrow-derived hemopoietic precursors commit to the T cell lineage only after arrival in the thymic microenvironment. J Immunol 2007; 178: 858-68.
25. Chervenick PA, Boggs DR, Marsh JC, Cartwright GE, Wintrobe MM,. Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol 1968; 215: 353-60.
26. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, Côté D, Rowe DW, Lin CP, Scadden DT,. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 2008.
27. Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, Frenette PS,. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 2003; 102: 2060-7.
28. Gothot A, Pyatt R, McMahel J, Rice S, Srour EF,. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 1997; 90: 4384-93.
29. Sipkins DA, Wei X, Wu JW, Runnels JM, Côté D, Means TK, Luster AD, Scadden DT, Lin CP,. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005; 435: 969-73.
30. Varnum-Finney B, Purton LE, Yu M, Brashem-Stein C, Flowers D, Staats S, Moore KA, Le Roux I, Mann R, Gray G, Artavanis-Tsakonas S, Bernstein ID,. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998; 91: 4084-91.
31. Schroeder T, Kohlhof H, Rieber N, Just U,. Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression. J Immunol 2003; 170: 5538-48.
32. Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI,. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood 2007; 109: 507-15.
33. Okajima T, Xu A, Irvine KD,. Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe. J Biol Chem 2003; 278: 42340-5.
34. Sandy AR, Maillard I,. Notch signaling in the hematopoietic system. Expert Opin Biol Ther 2009; 9: 1383-98.
35. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS,. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11: 299-308.
36. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH,. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007; 129: 1081-95.
37. Haltiwanger RS, Lowe JB,. Role of glycosylation in development. Annu Rev Biochem 2004; 491-537.
38. Gonzalez de Peredo A, Klein D, Macek B, Hess D, Peter-Katalinic J, Hofsteenge J,. C-mannosylation and o-fucosylation of thrombospondin type 1 repeats. Mol Cell Proteomics 2002; 1: 11-8.
39. Hofsteenge J, Huwiler KG, Macek B, Hess D, Lawler J, Mosher DF, Peter-Katalinic J,. C-mannosylation and O-fucosylation of the thrombospondin type 1 module. J Biol Chem 2001; 276: 6485-98.
40. Buko AM, Kentzer EJ, Petros A, Menon G, Zuiderweg ER, Sarin VK,. Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator. Proc Natl Acad Sci USA 1991; 88: 3992-6.
41. Wang LW, Dlugosz M, Somerville RP, Raed M, Haltiwanger RS, Apte SS,. O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: implications for the ADAMTS superfamily. J Biol Chem 2007; 282: 17024-31.
42. Ricketts LM, Dlugosz M, Luther KB, Haltiwanger RS, Majerus EM,. O-fucosylation is required for ADAMTS13 secretion. J Biol Chem 2007; 282: 17014-23.
43. Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N,. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 2008; 99: 1304-10.